...
首页> 外文期刊>Medical Journal Armed Forces India >Distribution of hepatitis B virus genotype and cancer predicting precore and basal core promoter mutations
【24h】

Distribution of hepatitis B virus genotype and cancer predicting precore and basal core promoter mutations

机译:乙型肝炎病毒基因型和癌症分布预测前核心和基础核心启动子突变

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Chronic hepatitis B (CHB) infection which is associated with an increased risk of developing liver disease including cirrhosis and hepatocellular carcinoma. Viral factors that may increase the risk for HCC development include HBV DNA level, genotypes, and naturally occurring mutations such as hepatitis B virus precore (PC) (G1896A) and basal core promoter (BCP) A1762T/G1764A double mutations. HBV genotypes and subgenotypes can significantly influence HBeAg seroconversion rates, viremia levels, mutational patterns that could significantly influence the heterogeneity in clinical manifestations and even response to antiviral therapy.Method: 94 CHB infected individuals with detectable serum HBV DNA levels were studied. HBsAg, HBeAg, anti-HBc IgM antibody estimations were done by ELISA. HBV DNA estimation was done. The HBV genotypes were determined by TSP-PCR and 10 samples randomly selected for DNA sequencing. PC and BCP mutations were determined by DNA sequence analysis of core region.Result: Of 94 study participant samples with detectable serum HBV DNA levels, 75 were successfully genotyped and sequenced for BCP/PC region. 30/75 (40%) harbored PC and BCP mutations. The total Double mutations of BCP at A1762T/G1764A nucleotide positions, and PC mutation at G1896A nucleotide position were seen in 29.3% and 21.3%, respectively. All 75 isolates were subtype D using TSP-PCR. However, by sequencing 2/10 were subtype A, while 8 were subtype D.Conclusion: Our study reinforces that D is the predominant genotype in Indian population. It reveals that Indian CHB subjects have increased prevalence of BCP & PC mutations, which possibly may lead to development of HCC.
机译:背景:慢性乙型肝炎(CHB)感染与发生包括肝硬化和肝细胞癌在内的肝脏疾病的风险增加有关。可能增加肝癌发生风险的病毒因素包括HBV DNA水平,基因型和自然发生的突变,例如乙型肝炎病毒前核(PC)(G1896A)和基础核心启动子(BCP)A1762T / G1764A双突变。 HBV基因型和亚基因型可以显着影响HBeAg的血清转化率,病毒血症水平,突变模式,这些突变模式可以显着影响临床表现的异质性甚至对抗病毒治疗的反应。方法:研究94名CHB感染者的血清HBV DNA水平可检测。通过ELISA对HBsAg,HBeAg,抗HBc IgM抗体进行评估。进行了HBV DNA评估。通过TSP-PCR确定HBV基因型,并随机选择10个样品进行DNA测序。结果:在94例可检测血清HBV DNA水平的研究参与者样本中,成功进行了75种BCP / PC区域的基因分型和测序。 30/75(40%)具有PC和BCP突变。在A1762T / G1764A核苷酸位置的BCP的总Double突变和在G1896A核苷酸位置的PC的总突变分别为29.3%和21.3%。使用TSP-PCR,所有75种分离物均为D亚型。然而,通过测序,2/10是A亚型,而8是D亚型。结论:我们的研究强调D是印度人群中的主要基因型。这表明印度CHB受试者的BCP和PC突变患病率增加,这可能导致肝癌的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号